Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 3,837 TARS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 3,837 | n/a |
| Jun 16, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,954 | n/a |
| Apr 21, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 1,800,965 | n/a |
| Jun 16, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |
| Mar 11, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 7,000 | $90.2K |
| Jun 25, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |
| Jun 14, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 5,000 | n/a |
| Dec 19, 2023 | Tarsus Pharmaceuticals, Inc. (TARS) | Purchase | 1,000 | $19.0K |
| Jun 26, 2023 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 5,000 | n/a |
| Jun 21, 2023 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,000 | n/a |